A conditioned response as a measure of impulsive-compulsive behaviours in Parkinson's disease

PLoS One. 2014 Feb 24;9(2):e89319. doi: 10.1371/journal.pone.0089319. eCollection 2014.

Abstract

Objectives: Parkinson's Disease patients wore a device on the wrist that gave reminders to take levodopa and also measured bradykinesia and dyskinesia. Consumption of medications was acknowledged by placing the thumb on the device. Some patients performed this acknowledgement repeatedly and unconsciously. This study examines whether this behaviour reflected increased impulsivity.

Methods and results: Twenty five participants were selected because they had i) excess acknowledgements described above or ii) Impulsive-Compulsive Behaviours or iii) neither of these. A blinded assessor applied clinical scales to measure Impulsive-Compulsive Behaviours, cognition, depression, anxiety and apathy. A Response Ratio, representing the number of acknowledgements/number of doses (expressed as a percentage) was tightly correlated with ratings of Impulsive-Compulsive Behaviours (r² = 0.79) in 19/25 subjects. Some of these patients had dyskinesia, which was higher with extraneous responses than with response indicating medication consumption. Six of the 25 subjects had high Impulsive-Compulsive Behaviour Scores, higher apathy scores, low levels of dyskinesia and normal Response Ratios. Patients without ICB (low RR) also had low dyskinesia levels regardless of the relevance of the response.

Conclusion: An elevated Response Ratio is a specific measure of a type of ICB where increased incentive salience is attributed to cues by the presence of high striatal dopamine levels, manifested by high levels of dyskinesia. This study also points to a second form of ICBs which occur in the absence of dyskinesia, has normal Response Ratios and higher apathy scores, and may represent prefrontal pathology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anxiety / drug therapy
  • Anxiety / physiopathology
  • Apathy / drug effects
  • Apathy / physiology
  • Compulsive Behavior / drug therapy
  • Compulsive Behavior / physiopathology*
  • Conditioning, Psychological / drug effects
  • Conditioning, Psychological / physiology*
  • Depression / drug therapy
  • Depression / physiopathology
  • Disruptive, Impulse Control, and Conduct Disorders / drug therapy
  • Disruptive, Impulse Control, and Conduct Disorders / physiopathology*
  • Dyskinesias / drug therapy
  • Dyskinesias / physiopathology
  • Humans
  • Hypokinesia / drug therapy
  • Hypokinesia / physiopathology
  • Impulsive Behavior / drug effects
  • Impulsive Behavior / physiology*
  • Levodopa / therapeutic use
  • Middle Aged
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology*
  • Weights and Measures

Substances

  • Levodopa

Grants and funding

Funding was provided by the Medical Research Council Funds. MH is a Medical Practitioner Fellow supported by the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.